These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7876365)

  • 21. Stability of amlodipine besylate in two liquid dosage forms.
    Nahata MC; Morosco RS; Hipple TF
    J Am Pharm Assoc (Wash); 1999; 39(3):375-7. PubMed ID: 10363465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C.
    Nahata MC; Morosco RS; Trowbridge JM
    Am J Health Syst Pharm; 2000 Jun; 57(12):1141-3. PubMed ID: 10911513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures.
    Nahata MC
    Int J Pharm Compd; 2016; 20(2):164-6. PubMed ID: 27323428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of reconstituted fluconazole oral suspension in plastic bottles and oral syringes.
    Dentinger PJ; Swenson CF
    Ann Pharmacother; 2009 Mar; 43(3):485-9. PubMed ID: 19208778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of extemporaneously prepared cinacalcet oral suspensions.
    Thomson K; Hutchinson DJ; Chablani L
    Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of extemporaneous suspensions of carbamazepine.
    Burckart GJ; Hammond RW; Akers MJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1929-31. PubMed ID: 7325176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of compounded thioguanine oral suspensions.
    Aliabadi HM; Romanick M; Somayaji V; Mahdipoor P; Lavasanifar A
    Am J Health Syst Pharm; 2011 May; 68(10):900-8. PubMed ID: 21546641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stability of an extemporaneously compounded minoxidil oral suspension.
    Song Y; Chin ZW; Ellis D; Lwin EMP; Turner S; Williams D; Garg S
    Am J Health Syst Pharm; 2018 Mar; 75(5):309-315. PubMed ID: 29472513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of extemporaneously prepared rufinamide oral suspensions.
    Hutchinson DJ; Liou Y; Best R; Zhao F
    Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of allopurinol and of five antineoplastics in suspension.
    Dressman JB; Poust RI
    Am J Hosp Pharm; 1983 Apr; 40(4):616-8. PubMed ID: 6846371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the Physical, Chemical and Microbiological Stability of Losartan Potassium 5 mg/mL Extemporaneous Oral Liquid Suspension.
    Foley L; Toney J; Barlow JW; O'Connor M; Fitzgerald-Hughes D; Ramtoola Z
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33435555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Nguyen AT; Morris TC; Graves RA
    Int J Pharm Compd; 2019; 23(2):157-162. PubMed ID: 31085781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of an extemporaneously compounded terbutaline sulfate oral liquid.
    Horner RK; Johnson CE
    Am J Hosp Pharm; 1991 Feb; 48(2):293-5. PubMed ID: 2003504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of amiodarone in an oral suspension stored under refrigeration and at room temperature.
    Nahata MC
    Ann Pharmacother; 1997; 31(7-8):851-2. PubMed ID: 9220043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of flucytosine in an extemporaneously compounded oral liquid.
    Wintermeyer SM; Nahata MC
    Am J Health Syst Pharm; 1996 Feb; 53(4):407-9. PubMed ID: 8673661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of extemporaneously prepared saquinavir formulations.
    Tan LK; Thenmozhiyal JC; Ho PC
    J Clin Pharm Ther; 2003 Dec; 28(6):457-63. PubMed ID: 14651667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of an extemporaneously compounded levothyroxine sodium oral liquid.
    Boulton DW; Fawcett JP; Woods DJ
    Am J Health Syst Pharm; 1996 May; 53(10):1157-61. PubMed ID: 8734676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of an extemporaneously prepared thalidomide suspension.
    Kraft S; Johnson CE; Tyler RP
    Am J Health Syst Pharm; 2012 Jan; 69(1):56-8. PubMed ID: 22180553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of flecainide acetate in an extemporaneously compounded oral suspension.
    Wiest DB; Garner SS; Pagacz LR; Zeigler V
    Am J Hosp Pharm; 1992 Jun; 49(6):1467-70. PubMed ID: 1529992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.